{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:04:02Z","timestamp":1790845442819,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T00:00:00Z","timestamp":1492128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.rgmx.2017.03.004","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T22:47:11Z","timestamp":1499122031000},"page":"41-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Perspectivas hist\u00f3ricas y vigentes sobre la infecci\u00f3n por Clostridium difficile"],"prefix":"10.1016","volume":"83","author":[{"given":"D.A.","family":"\u00c1lvarez-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Gonz\u00e1lez-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gonz\u00e1lez-Hermosillo-Cornejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A.","family":"Franyuti-Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"D\u00edaz-Gir\u00f3n-Gidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"V\u00e1zquez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmx.2017.03.004_bib0280","first-page":"299","article-title":"One Health: The human-animal-environment interfaces in emerging infectious diseases","volume":"365","author":"Squire","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0285","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/525047","article-title":"Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile associated diarrhea","volume":"197","author":"Chang","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0290","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1469-0691.2011.03571.x","article-title":"The economic burden of Clostridium difficile","volume":"18","author":"McGlone","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0295","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile-more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0300","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0305","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4067\/S0716-10182013000200008","article-title":"Abordaje multidisciplinario de la infecci\u00f3n por Clostridium difficile","volume":"30","author":"P\u00e9rez","year":"2013","journal-title":"Rev Chilena Infectol"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0310","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archpedi.1935.01970020105010","article-title":"Intestinal flora in new-born infants with a description of a new pathogenic anaerobe, Bacillus difficilis","volume":"49","author":"Hall","year":"1935","journal-title":"Am J Dis Childhood"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0315","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/bmj.1.6071.1246","article-title":"Undescribed toxin in pseudomembranous colitis","volume":"1","author":"Larson","year":"1977","journal-title":"BMJ"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0320","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/0016-5085(78)90457-2","article-title":"Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis","volume":"75","author":"Bartlett","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0325","first-page":"53","article-title":"Gastroenterostomy for cicatrizing ulcer of the pylorus","volume":"4","author":"Finney","year":"1893","journal-title":"Bull Johns Hopkins Hosp"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0330","first-page":"39","article-title":"Pseudomembranous colitis following aureomycin and chloramphenicol","volume":"54","author":"Reiner","year":"1952","journal-title":"Arch Pathol"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0335","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-81-4-429","article-title":"Clindamycin-associated colitis: A prospective study","volume":"81","author":"Tedesco","year":"1974","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0340","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0345","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMcp011603","article-title":"Clinical practice. Antibiotic-associated diarrhea","volume":"346","author":"Bartlett","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0350","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamainternmed.2013.7056","article-title":"Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011","volume":"173","author":"Chitnis","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0355","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ajg.2011.398","article-title":"The epidemiology of community acquired Clostridium difficile infection: A population based study","volume":"107","author":"Khanna","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0360","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-145-10-200611210-00008","article-title":"Narrative review: The new epidemic of Clostridium difficile-associated enteric disease","volume":"145","author":"Bartlett","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0365","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nature07822","article-title":"Toxin B is essential for virulence of Clostridium difficile","volume":"458","author":"Lyras","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0370","doi-asserted-by":"crossref","first-page":"e1002727","DOI":"10.1371\/journal.ppat.1002727","article-title":"Secretion of Clostridium difficile Toxins A and B requires the holin-like protein TcdE","volume":"8","author":"Govind","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0375","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1099\/jmm.0.47775-0","article-title":"Clostridium difficile toxin synthesis is negatively regulated by TcdC","volume":"57","author":"Dupuy","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0380","first-page":"473","article-title":"Infecci\u00f3n por Clostridium difficile: Epidemiolog\u00eda, diagn\u00f3stico y estrategias terap\u00e9uticas","volume":"25","author":"Meyer","year":"2014","journal-title":"Rev Med Clin Condes"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0385","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3390\/toxins2071848","article-title":"The enterotoxicity of Clostridium difficile toxins","volume":"2","author":"Sun","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0390","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/CMR.18.2.247-263.2005","article-title":"Clostridium difficile toxins: Mechanism of action and role in disease","volume":"18","author":"Voth","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0395","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.eimc.2012.12.010","article-title":"Infecciones producidas por Clostridium difficile","volume":"31","author":"Rodr\u00edguez-Pardo","year":"2013","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0400","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM200002103420604","article-title":"Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A","volume":"342","author":"Kyne","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0405","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00365520802321238","article-title":"Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents","volume":"44","author":"Nomura","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0410","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/cid\/cir643","article-title":"Relapse versus reinfection: Surveillance of Clostridium difficile infection","volume":"53","author":"Kamboj","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0415","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1586\/eri.10.95","article-title":"Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients","volume":"8","author":"Chopra","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0420","doi-asserted-by":"crossref","first-page":"e89417","DOI":"10.1371\/journal.pone.0089417","article-title":"Effects of \u03b2-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea","volume":"9","author":"Knecht","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0425","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrmicro2164","article-title":"Clostridium difficile infection: new developments in epidemiology and pathogenesis","volume":"7","author":"Rupnik","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0430","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ismej.2007.3","article-title":"Long-term ecological impacts of antibiotic administration on the human intestinal microbiota","volume":"1","author":"Jernberg","year":"2007","journal-title":"ISME J"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0435","doi-asserted-by":"crossref","first-page":"147","DOI":"10.20524\/aog.2016.0006","article-title":"Clostridium difficile infection: A review of current and emerging therapies","volume":"29","author":"Ofosu","year":"2016","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0440","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.crad.2006.03.009","article-title":"Pseudomembranous colitis revisited: Spectrum of imaging findings","volume":"61","author":"Ramachandran","year":"2006","journal-title":"Clin Radiol."},{"key":"10.1016\/j.rgmx.2017.03.004_bib0445","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3760\/cma.j.issn.0366-6999.20111537","article-title":"Current role of surgery for the treatment of fulminant Clostridium difficile colitis","volume":"126","author":"Wang","year":"2013","journal-title":"Chin Med J Engl"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0450","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.crad.2006.01.009","article-title":"Ultrasound diagnosis of clinically undetected Clostridium difficile toxin colitis","volume":"61","author":"Razzaq","year":"2006","journal-title":"Clin Radiol"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0455","doi-asserted-by":"crossref","first-page":"75","DOI":"10.7861\/clinmedicine.11-1-75","article-title":"Prevention and treatment of Clostridium difficile infection","volume":"11","author":"Gouliouris","year":"2011","journal-title":"Clin Med"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0460","unstructured":"NHS Salford. Medicines Management Team. Oral Vancomycin Information Sheet 2001 [consultado 12 Mar 2017]. Disponible en: http:\/\/www.salfordccg.nhs.uk\/download.cfm?doc=docm93jijm4n3351.pdf&ver=3547"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0465","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4103\/0971-5916.159251","article-title":"Fidaxomicin\u2014the new drug for Clostridium difficile infection","volume":"141","author":"Vaishnavi","year":"2015","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0470","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ajg.2013.4","article-title":"Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections","volume":"108","author":"Surawicz","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0475","first-page":"1","article-title":"Treatment of relapsing Clostridium difficile infection using fecal microbiota transplantation","volume":"7","author":"Rahul","year":"2014","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2016.00120","article-title":"Rifaximin improves Clostridium difficile toxin a-induced toxicity in Caco-2 cells by the PXR-dependent TLR4\/MyD88\/NF-\u03baB pathway","volume":"7","author":"Esposito","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0485","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.anaerobe.2009.08.004","article-title":"Rifaximin redux: Treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment","volume":"15","author":"Johnson","year":"2009","journal-title":"Anaerobe"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0490","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile infection","volume":"372","author":"Leffler","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0495","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJMoa0907635","article-title":"Treatment with monoclonal antibodies against Clostridium difficile toxins","volume":"362","author":"Lowy","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0500","doi-asserted-by":"crossref","first-page":"e89356","DOI":"10.1371\/journal.pone.0089356","article-title":"Discovery of selective inhibitors of the Clostridium difficile dehydroquinate dehydratase","volume":"8","author":"Ratia","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0505","unstructured":"Department of Health and Health Protection Agency. Clostridium difficile infection: How to deal with the problem 2008 [consultado 12 Mar 2017]. Disponible en: www.hpa.org.uk\/web\/HPAwebFile\/HPAweb_C\/1232006607827"},{"issue":"Suppl 2","key":"10.1016\/j.rgmx.2017.03.004_bib0510","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1093\/cid\/civ138","article-title":"Prevention of Clostridium difficile infection with probiotics","volume":"60","author":"Evans","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0515","first-page":"156","article-title":"Consenso mexicano sobre probi\u00f3ticos en gastroenterolog\u00eda","volume":"82","author":"Valdovinos","year":"2017","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0520","doi-asserted-by":"crossref","first-page":"e0129079","DOI":"10.1371\/journal.pone.0129079","article-title":"First Report of Clostridium difficile NAP1\/027 in a Mexican Hospital","volume":"10","author":"Camacho-Ortiz","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0525","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3201\/eid1808.120211","article-title":"Epidemic Clostridium difficile ribotype 027 in Chile","volume":"18","author":"Hern\u00e1ndez-Rocha","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0530","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4067\/S0716-10182015000600002","article-title":"Quinolonas. Perspectivas actuales y mecanismos de resistencia","volume":"32","author":"\u00c1lvarez-Hern\u00e1ndez","year":"2015","journal-title":"Rev Chilena Infectol"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0535","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S0022172400062483","article-title":"Clostridium difficile in general practice and community health","volume":"96","author":"Riley","year":"1986","journal-title":"J Hyg"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0540","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijid.2015.06.007","article-title":"Emergence of community-acquired Clostridium difficile infection: The experience of a French hospital and review of the literature","volume":"37","author":"Ogielska","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0545","first-page":"63","article-title":"Community-acquired Clostridium difficile infection: An increasing public health threat","volume":"7","author":"Gupta","year":"2014","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.rgmx.2017.03.004_bib0550","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/511798","article-title":"Recommendations for surveillance of Clostridium difficile associated disease","volume":"28","author":"McDonald","year":"2007","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037509061730068X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037509061730068X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T06:05:01Z","timestamp":1719295501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037509061730068X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S037509061730068X"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmx.2017.03.004","relation":{},"ISSN":["0375-0906"],"issn-type":[{"value":"0375-0906","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perspectivas hist\u00f3ricas y vigentes sobre la infecci\u00f3n por Clostridium difficile","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2017.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}